+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Canada Graves' disease Market 2019-2025

  • ID: 5116625
  • Report
  • February 2020
  • Region: Canada
  • Orion Market Research Private Limited

FEATURED COMPANIES

  • Abbott Laboratories Inc.
  • Allergan PLC
  • Eli Lilly and Co.
  • GlaxoSmithKline PLC
  • Johnson & Johnson
  • Merck & Co. Inc.
Canada Graves’ disease Market Size, Share & Trends Analysis Report by Diagnosis (Ultrasound, Imaging Tests, Radioactive Iodine Uptake, and Blood Sample), by Treatment (Anti- Thyroid Medication, Radioactive Iodine Therapy, and Surgery) Forecast Period 2019-2025.

Canada Graves’ disease market is growing at a CAGR of around 6.3% during the forecast period. Due to increasing awareness of thyroid disease in the country by various government organizations, the Canada Graves’ disease market is expected to grow. For instance, June is celebrated as thyroid awareness month in Canada. The Thyroid Foundation of Canada (TFC), a non-profit organization established in 1980 with the objective of supporting patients suffering from thyroid disease. The foundation has given nearly $1 million for researches on thyroid disease. This funding supports in researches on thyroid disease.

As Grave’s is the most common autoimmune thyroid disease, this may result in a significant rise in researches for discovering effective medication for patients. Moreover, according to TFC, Grave’s disease is by far the most common cause of hyperthyroidism in Canada. Grave’s disease affects nearly one in every 100 people in Canada, which in turn creates significant scope for the growth of Canada Graves’ disease market.

Further, a significant number of smokers in Canada are also a major cause of Grave’s disease in Canada. According to Statistics Canada, in 2017, 16.2% of Canadians aged 12 and over, which is nearly 5 million people smoked either daily or occasionally. Of the 5 million current smokers, 3.6 million smoked cigarettes every day. According to the British Thyroid Foundation, Cigarette smoking is identified to have a key influence on Grave’s disease and on thyroid eye disease (TED).

Smoking can lead to Grave’s disease as it consists of thousands of chemicals and among which some can stimulate the immune system for reacting against the thyroid. Moreover, smokers with Grave’s disease are nearly two times more expected to develop TED. This represents the relation of smoking with Grave’s disease and thereby results in the adoption of anti-thyroid medication for the treatment of the condition, which in turn positively affects the Canada Graves’ disease market growth.

Research Methodology:

The market study of the Canada Graves’ disease market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The research team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. The analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to the reports.

Secondary Sources Include:
  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation:

1. Canada Graves’ Disease Market Research and Analysis by Diagnosis
2. Canada Graves’ Disease Market Research and Analysis by Treatment

The Report Covers:
  • Comprehensive Research Methodology of the Canada Graves’ disease market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the Canada Graves’ disease market.
  • Insights about market determinants which are stimulating the Canada Graves’ disease market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Abbott Laboratories Inc.
  • Allergan PLC
  • Eli Lilly and Co.
  • GlaxoSmithKline PLC
  • Johnson & Johnson
  • Macleods Pharmaceuticals Ltd.
  • Merck & Co. Inc.
  • Mylan NV
  • Novartis International AG
  • Pfizer Inc.
  • Sanofi SA
  • Takeda Pharmaceutical Co. Ltd.
Note: Product cover images may vary from those shown